Insider · CIK 0001334365
Lee Yuchun
Reports to the SEC for 2 companies · WALTHAM, MA
Transactions
50
Companies
2
Filings
4
CIK
0001334365
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2023-01-27 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$103K |
| 2023-01-27 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$122K |
| 2023-01-27 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$313K |
| 2023-01-27 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$25.9K |
| 2023-01-27 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$289K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$95.3K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$361K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$318K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$153K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$128K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$218K |
| 2023-01-26 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-25 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$289K |
| 2023-01-25 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$250K |
| 2023-01-25 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$823K |
| 2023-01-25 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$182K |
| 2023-01-25 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-24 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$289K |
| 2023-01-24 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$784K |
| 2023-01-24 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$467K |
| 2023-01-24 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-23 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$154K |
| 2023-01-23 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$664K |
| 2023-01-23 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-18 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$31.9K |
| 2023-01-18 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$138K |
| 2023-01-18 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-01-17 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$289K |
| 2023-01-17 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$1.25M |
| 2023-01-17 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-05-01 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)A Award | — |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$163K |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$108K |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$286K |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$140K |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$34.1K |
| 2022-04-18 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$163K |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$273K |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$72.8K |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$116K |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$116K |
| 2022-04-14 | VRTXVERTEX PHARMACEUTICALS INC / MA · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-04-13 | VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion | +$163K |
| 2022-04-13 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$5,066.82 |
| 2022-04-13 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$85.1K |
| 2022-04-13 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$65K |
| 2022-04-13 | VRTXVERTEX PHARMACEUTICALS INC / MAS Sale | −$85.9K |
Recent filings
- 4Lee Yuchun0001209191-23-027034SEC(opens sec.gov)
- 4Lee Yuchun0001209191-23-005712SEC(opens sec.gov)
- 4Lee Yuchun0001209191-23-005234SEC(opens sec.gov)
- 4Lee Yuchun0001209191-23-004816SEC(opens sec.gov)
Companies
Address
170 TRACER LANE
WALTHAM, MA, 02451